GSK: weak buy signal, stop a hair away
GSK stock: +0.6% for the week, but sellers dominate the last session
GSK: weak buy signal, stop a hair away
Our view last week
GSK closes the week up 0.2%, but under the surface the signals are fading: the last candle shows price falling on rising volume, a classic divergence, and candle-body conviction keeps thinning out. The price stays compressed against the 50-week moving average and the weekly ADX is easing, a sign the trend is losing steam. The buy signal that fired three weeks ago is holding, but the confirmation week closed in the red and our model had already flagged an early-exit warning.
This week's summary
GSK closes the week up 0.6%, but the gain hides cracks: on the last candle sellers were sharply dominant and buyer dominance is collapsing, just as flagged last week. The price is boxed into a very tight band between the daily pivot and the Ichimoku cloud floor. Earnings are now behind us, the gap risk has passed. GSK stock stays a cautious technical analysis case: the buy signal holds, but without conviction.
IQS Phase
45
ordinary
Signal Strength
37
medium · weak
Sizing
REDUCED
Ranking
#50 / 61
EU-UK stocks in progress
Trade P&L %
-4.14%
from signal to date, no stop loss
Rank position
ranks 50th among the 61 Longs already running for European-UK stocks in our ranking, with a signal strength of 37 out of 100.
Sector context
SectorEuropean
Benchmark ETFEXV4
Sector regimein positive regime
Performanceweekly -0.61% · monthly -2.43%
GSK belongs to the european sector (reference ETF EXV4). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content